Sun Rises For GSK's Trelegy And Shingrix While It Sets For Advair
Executive Summary
The drug maker is in the midst of launching several new drugs, including the Shingrix vaccine, the triple COPD therapy Trelegy and the HIV regimen Juluca, hoping new drugs will drive growth as Advair sunsets.